Original research article| Volume 88, ISSUE 3, P408-412, September 2013

Examining the role of oral contraceptive users as an experimental and/or control group in athletic performance studies



      This study was conducted to examine the effect of oral contraceptives on endogenous reproductive hormone levels in order to assess the suitability of oral contraceptive users as experimental and/or control groups in human performance studies.

      Study Design

      Ninety-five females who were taking a variety of oral contraceptives (2 types and 11 brands) were recruited. A single blood sample was analysed for endogenous concentrations of oestradiol and progesterone.


      There were significant differences (p<.05) in circulating oestradiol and progesterone as a result of oral contraceptive type and brand. Overall, oral contraceptive use resulted in low levels of oestradiol and progesterone and large variation in hormone concentration when multiple brands were analysed together.


      This study indicates that future studies should employ a single pill type and brand when using oral contraceptive users as either a control or experimental group and that comparison between oral contraceptive users as a control group and the early follicular phase of the menstrual cycle as an experimental group should be reconsidered.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lebrun C.M.
        Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance.
        Sports Med. 1993; 16: 400-430
        • Cable N.T.
        • Elliott K.J.
        The influence of reproductive hormones on muscle strength.
        Biol Rhythms Res. 2004; 35: 235-244
        • Burrows M.
        • Peters C.E.
        The influence of oral contraceptives on athletic performance in female athletes.
        Sports Med. 2007; 37: 557-574
        • Phillips S.K.
        • Sanderson A.G.
        • Birch K.
        • Bruce S.A.
        • Woledge R.C.
        Changes in maximal voluntary force of the human adductor pollicis muscle during the menstrual cycle.
        J Physiol. 1996; 496: 551-557
        • Sarwar R.
        • Beltran Niclos B.
        • Rutherford O.M.
        Changes in muscle strength, relaxation rate and fatigability during the human menstrual cycle.
        J Physiol. 1996; 493: 267-272
        • Sunderland C.
        • Nevill M.
        Effect of the menstrual cycle on performance of intermittent, high-intensity shuttle running in a hot environment.
        EJAP. 2003; 88: 345-352
        • Elliott K.J.
        • Cable N.T.
        • Reilly T.
        Does oral contraceptive use affect maximum force production in women?.
        BJSM. 2005; 39: 15-19
        • Peters C.
        • Burrows M.
        Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
        Contraception. 2006; 74: 487-491
        • Ojeda S.R.
        Textbook of endocrine physiology. 2nd ed. Oxford University Press, Oxford1992
        • Wurtman R.J.
        Brain monoamines and endocrine function.
        Neurosci Res Program Bull. 1971; 9: 171-297
        • Halaz B.
        Hypothalamic mechanisms controlling pituitary function.
        Prog Brain Res. 1972; 38: 97-122
        • Hohlweg W.
        • Junkmann K.
        Die hormonal nervöse Regulierung der Funktion des Hypophysenvorderlappens.
        Klin Wschr. 1932; 11: 321-323
        • Lunenfeld B.
        • Kraiem Z.
        • Eshkol A.
        The function of the growing follicle.
        J Reprod Fert. 1975; 45: 567-574
        • Yen S.S.C.
        Regulation of the hypothalamic–pituitary–ovarian axis in women.
        J Reprod Fert. 1977; 51: 181-191
        • Nudemberg F.
        • Kothari M.
        • Karam K.
        • Taymor M.L.
        Effects of the "pill-a-month" on the hypothalamic–pituitary–ovarian axis.
        Fertil Steril. 1973; 24: 185-190
        • Hansen A.P.
        • Weeke J.
        Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives.
        Scand J Clin Lab Invest. 1974; 34: 199-205
        • Petrofsky J.S.
        • Ledonne D.M.
        • Rinehart J.S.
        • Lind A.E.
        Isometric strength and endurance during the menstrual cycle.
        Eur J Appl Physiol Occup Physiol. 1976; 35: 1-10
        • Bryner R.W.
        • Toffle R.C.
        • Ullrich I.H.
        • Yeater R.A.
        Effect of low dose oral contraceptives on exercise performance.
        BJSM. 1996; 30: 36-40
        • Lynch N.J.
        • De Vito G.
        • Nimmo M.A.
        Low dosage monophasic oral contraceptive use and intermittent exercise performance and metabolism in humans.
        EJAP. 2001; 84: 296-301
        • Lebrun C.M.
        • Petit M.A.
        • McKenzie D.C.
        • Taunton J.E.
        • Prior J.C.
        Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial.
        BJSM. 2003; 37: 315-320
        • Giacomoni M.
        • Bernard T.
        • Gavarry O.
        • Altare S.
        • Falgairette G.
        Diurnal variations in ventilator and cardiorespiratory responses to submaximal treadmill exercise in females.
        EJAP. 1999; 80: 591-597
        • Giacomoni M.
        • Falgairette G.
        Influence of menstrual cycle phase and oral contraceptive use on the time-of-day effect on maximal anaerobic power.
        Biol Rhythm Res. 1999; 30: 583-591
        • Armstrong L.E.
        • Maresh C.M.
        • Keith N.R.
        • Elliott T.A.
        • Vanheest J.L.
        • Scheett T.P.
        • et al.
        Heat acclimation and physical training adaptations of young women using different contraceptive hormones.
        Am J Physiol Endocrinol Metab. 2005; 288: E868-E875
        • Greer J.B.
        • Modugno F.
        • Allen G.O.
        • Ness R.B.
        Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
        Obstet Gynecol. 2005; 105: 731-740
        • Joint Formulary Committee
        British national formulary. 63rd ed. British Medical Association and the Royal Pharmaceutical Society, London2012
        • Bonen A.
        • Ling W.Y.
        • MacIntyre K.P.
        • Neil R.
        • McGrail J.C.
        • Belcastro A.N.
        Effects of exercise on serum concentrations of FSH, LH, progesterone and estradiol.
        EJAP. 1979; 42: 15-23
        • Reichman M.E.
        • Judd J.T.
        • Longcope C.
        • Schatzkin A.
        • Clevidence B.A.
        • Nair P.P.
        • et al.
        Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women.
        J Natl Cancer Inst. 1993; 85: 722-727
        • Lucero J.
        • Harlow B.L.
        • Barbieri R.L.
        • Sluss P.
        • Cramer D.W.
        Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use.
        Fertil Steril. 2001; 76: 723-729
        • Bale P.
        • Davies J.
        Effects of menstruation and contraceptive pill on the performance of physical education students.
        BJSM. 1983; 17: 46-50
        • Wirth J.C.
        • Lohman T.G.
        The relationship of static muscle function to use of oral contraceptives.
        MSSE. 1982; 14: 16-20